重组人血管内皮抑素联合化疗治疗晚期头颈部癌疗效观察  被引量:2

The clinical effects and safety of Rh-endostatin/Endostar combined chemotherapy for metastatic head and neck neoplasms

在线阅读下载全文

作  者:王峥[1] 董济民[1] 李民[1] 张晓炜[1] 丁海霞[1] 李蓉[2] 

机构地区:[1]西安市中心医院,西安710003 [2]西安交通大学医学院第一附属医院

出  处:《陕西医学杂志》2011年第10期1369-1371,共3页Shaanxi Medical Journal

摘  要:目的:观察重组人血管内皮抑素联合化疗治疗晚期头颈部癌的疗效及安全性。方法:22例综合治疗后出现转移的晚期头颈部癌患者,接受恩度联合化疗的治疗方案。重组人血管内皮抑素(恩度)12~15mg/d,d1~d14,21d为1周期;卡培他滨1500~2000mg/(m2.d),d1~d14,或替吉奥120mg/d,d1~d14,21d为1周期。每周期评价毒副反应,每2周期评价疗效,稳定和有效者继续治疗2~4周期。结果:22例患者共接受108个周期的化疗,中位4个周期,完全缓解(CR)0例,部分缓解(PR)2例,稳定(SD)14例,进展(PD)6例,总有效率RR(CR+PR)为9.09%,疾病控制率DCR(CR+PR+SD)为72.7%。中位疾病进展时间10个月,中位生存时间16个月。生活质量评价19例患者有不同程度的改善。与恩度相关的毒副反应主要为轻度的心脏毒副反应,包括T波和ST-T改变、轻度高血压,其它毒副反应与化疗药物相关。结论:血管内皮抑素联合卡培他滨或替吉奥治疗晚期头颈部癌具有一定疗效,可以改善患者的QOL、毒性低、安全性良好。Objective:To observe the clinical efficacy and safety of Rh-endostatin /Endostar,a new molecular targeted antitumor agent,combined with chemotherapy on metastatic head and neck neoplasms.Methods:22 cases of metastatic head and neck neoplasms confirmed by histopathology or cytopathology were administered of 12~15mg Rh-endostatin /Endostar from day1 to day14.The chemotherapy agents were: capecitabine 1500~2000mg/(m2.d),d1-d14,or TS-1 120mg/d,d1-d14,21 days was 1 cycle.The toxicity was evaluated after 1 cycle and the efficacy was evaluated after 2 cycles.Results:22cases completed 108 cycles with a median 4 cycles.There was no case achieved CR,2 cases achieved PR,9 cases were SD and 6 cases were PD,overall response rate(RR=CR+PR) was 9.09%,and disease control rate DCR(CR+PR+SD) was 72.7%.The quality of life(QOL) were improved in 19 cases(86.3%).The median TTP was 10 months and the median survival time was 16 months.The main toxicities related to endostar was mildly cardiac toxicity(ECG T wave and ST-T changes,mild hypertension) in 3cases,other toxicities were related to chemotherapy gents.Conclusion:There are better efficacy of endostar combined with the related chemotherapy on the metastatic head and neck neoplasms and QOL of such patients may be improved with low toxic and good safety,so it seems to be an effective salvage regime.

关 键 词:头颈部肿瘤/药物疗法 内皮抑素类/治疗应用 抗肿瘤联合化疗方案 

分 类 号:R739.91[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象